Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedChem

This article was originally published in The Gray Sheet

Executive Summary

President and Chief Operating Officer Edward Covell is appointed president of the company's Gesco International division, assuming responsibility for the intravenous access business. Covell's old post is not expected to be filled and he will continue to report to Chief Executive Officer Jonathan Donaldson. MedChem Senior VP-Sales & Marketing Bradford Gay is appointed president of MedChem's surgical division, overseeing the hemostasis business. The Woburn, Massachusetts firm says the restructuring will "sharpen its focus on its two strategic business units: the hemostasis business (the Avitene family of products) and the intravenous access business"
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002073

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel